microdosing glp-1 dosing chart Tirzepatide Chart: A Weekly Dose Guide That Works Microdosing GLP-1 Medications | Achieve

In Phase 3 trials, retatrutide 12 mg achieved 28.7% body weight reduction at 68 weeks, while mazdutide 9 mg achieved 20.1% at 60 weeks

Phase 2 = 38%

Multi-month options make ongoing care more predictable

Individuals with type 2 diabetes who have not achieved adequate blood sugar control with other oral medications or who require additional treatment beyond oral medications may be candidates for GLP-1 therapy

What This Means for Your Weight Loss Journey If youre considering GLP-1 treatment for weight loss, the choice between medication alone and a comprehensive medical program could determine both your timeline to success and your likelihood of achieving meaningful results

In the STEP UP clinical trial, the 7.2 mg dose produced a mean weight loss of 20.7% at 72 weeks, compared with 17.5% at the previously approved 2.4 mg dose and 2.4% with placebo